Breakdown | |||||
TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|---|
Income Statement | Total Revenue | ||||
2.52M | 4.75M | 3.95M | 2.33M | 110.96K | 0.00 | Gross Profit |
811.13K | 2.02M | 1.71M | 617.68K | 19.35K | 0.00 | EBIT |
-7.43M | -6.19M | -4.95M | -9.51M | -4.65M | -325.17K | EBITDA |
-6.63M | -5.26M | -4.32M | -8.55M | -4.61M | 0.00 | Net Income Common Stockholders |
-12.41M | -7.63M | -5.40M | -14.37M | -1.64M | -325.17K |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | ||||
14.37M | 14.17M | 18.53M | 26.62M | 32.78M | 1.96M | Total Assets |
24.08M | 24.08M | 30.14M | 32.94M | 36.30M | 3.97M | Total Debt |
811.05K | 1.72M | 1.77M | 1.50M | 866.50K | 86.77K | Net Debt |
-13.56M | -12.46M | -16.72M | -24.59M | -30.32M | -1.88M | Total Liabilities |
3.82M | 3.82M | 3.80M | 3.78M | 2.24M | 5.11M | Stockholders Equity |
20.07M | 20.07M | 26.06M | 28.48M | 34.06M | -1.14M |
Cash Flow | Free Cash Flow | ||||
-7.73M | -3.92M | -6.45M | -5.28M | -3.63M | -238.35K | Operating Cash Flow |
-4.79M | -3.23M | -4.39M | -4.88M | -3.36M | -238.35K | Investing Cash Flow |
-2.57M | -650.43K | -3.17M | -582.74K | -201.55K | -1.80M | Financing Cash Flow |
341.15K | -206.95K | -114.16K | 451.76K | 32.78M | 4.01M |
Red Light Holland’s subsidiary, Happy Caps Mushroom Farm, has secured a purchase order with Albertsons Companies for its first U.S. retail launch through Safeway stores in Oregon. This strategic partnership will introduce three varieties of Happy Caps Mushroom Home Grow Kits to 66 Safeway locations, marking a significant expansion into the U.S. market. The collaboration with Trailbridge Farms in Oregon ensures product freshness and improved margins, highlighting the growing demand for innovative mushroom products in the health and wellness sector.
Spark’s Take on TSE:TRIP Stock
According to Spark, TipRanks’ AI Analyst, TSE:TRIP is a Neutral.
Red Light Holland faces major challenges in profitability and cash flow, significantly impacting its financial health. The stock’s current technical indicators suggest bearish momentum, and its valuation is not appealing due to negative earnings. However, recent corporate events, including strategic partnerships and leadership enhancements, offer a glimmer of hope for future growth and operational improvement.
To see Spark’s full report on TSE:TRIP stock, click here.
Red Light Holland has appointed Michael Galloro to its Board of Directors, enhancing its leadership with his extensive experience in public markets, strategic transactions, and corporate governance. Galloro’s proven success in scaling consumer brands is expected to drive sustainable growth and enhance shareholder value as the company expands its functional mushroom and psilocybin truffle offerings.
Red Light Holland, through its subsidiary Happy Caps Mushroom Farms, has received an Informal Projection Letter from Costco Canada for 20,160 units of its ‘Mega Block’ 2kg Mushroom Home Grow Kits. This development, scheduled for delivery in May 2025, signifies a strengthened partnership with Costco Canada and highlights the growing demand for sustainable home grow kits. The company is also eyeing further expansion in North America, including potential orders with a major U.S. retailer.
Red Light Holland reported its financial results for the third quarter of 2025, highlighting a cash balance of $13.3 million and a revenue of $1.2 million for the quarter. Despite a slight decline in quarterly revenue due to lower wholesale mushroom sales and a returned purchase order from Costco Canada, the company achieved a year-over-year revenue increase of 5.1%. The company also reduced its EBITDA loss, reflecting its commitment to sustainable growth and strategic partnerships. Red Light Holland’s diversified portfolio and upcoming partnerships, including a re-order with Costco Canada and a new purchase order with a major U.S. retailer, position it for continued success in the emerging legal psilocybin market.
Red Light Holland’s subsidiary, Happy Caps, has gained Health Canada’s approval for their Functional Daily mushroom gummies, featuring Shiitake and Lion’s Mane mushrooms. This approval highlights the product’s compliance with safety, effectiveness, and quality standards, potentially enhancing the company’s market position in the health and wellness industry.
Red Light Holland has announced a new research and development plan in collaboration with Irvine Labs Inc., a DEA-registered and FDA-compliant facility. This partnership aims to enhance the shelf life of psilocybin products, which will facilitate commercialization in emerging legal markets. By leveraging proprietary dehydration and packaging techniques, the company intends to meet the growing demand for innovative mental health solutions. The move is expected to position Red Light Holland strategically within the global market for naturally derived therapeutic products.
Red Light Holland has appointed Keith Li as the new Chief Financial Officer, bringing over 15 years of experience in corporate accounting and financial strategy to the company. This leadership change is part of the company’s focus on advancing psilocybin access in emerging markets, supported by strong financial leadership. The company is also enthusiastic about its partnership with Irvine Labs, which could enable significant R&D and commercialization opportunities for psilocybin. The appointment of Li is expected to enhance financial efficiencies, support revenue expansion, and strengthen Red Light Holland’s position in the transformative natural plant and fungi medicines industry.